Objective: To explore the effects of microwave radiation on cognitive function and neuroinflammation in mice with experimental periodontitis, providing experimental evidence for understanding how environmental exposure may be linked to the risk of neurodegenerative diseases by modulating chronic inflammation as a shared pathological mechanism Methods: This study was approved by the Animal Ethics Committee of the Academy of Military Medical Sciences. C57BL/6J mice were randomly divided into a control group (C group, untreated), a microwave radiation group (R group, exposed to microwave radiation only), a periodontitis group (P group, ligation-induced periodontitis only), and a periodontitis + microwave radiation group (PR group, ligation-induced periodontitis plus microwave radiation exposure). A periodontitis model was established using the silk ligation method. Eight weeks after modeling, the R and PR groups were subjected to whole-body microwave radiation at 2 800 MHz and 10 mW/cm2 for 10 h/day for 7 consecutive days. Behavioral tests were conducted: the open field test and elevated plus maze test were used to assess anxiety-like behavior, the Y-maze test to evaluate spatial memory, and the novel object recognition test to assess learning and memory abilities. Micro-CT, hematoxylin & eosin staining (HE), and quantitative real-time polymerase chain reaction (qPCR) were used to analyze periodontal tissue pathology and local inflammation. Serum and brain levels of lipopolysaccharide (LPS), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were measured using enzyme-linked immunosorbent assay (ELISA). The composition of the oral microbiota was analyzed based on 16S rRNA sequencing. Results: Behavioral tests showed that anxiety-like behavior was significantly exacerbated in the R and PR groups, and spatial and recognition memory impairments in the PR and P groups were more severe compared with the R and C groups, respectively (P < 0.05). Histological and molecular biological analyses revealed that periodontal inflammation infiltration, alveolar bone resorption, and local expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) were further exacerbated in the PR and P groups compared with the R and C groups, respectively (P < 0.05). ELISA results showed that in serum, LPS levels in group P and group PR were increased compared with group C and group R, respectively. The levels of TNF-α, IL-1β, and IL-6 in group PR were significantly higher than those in group P and group R, with a synergistic increase in TNF-α level (P < 0.05). In brain tissue, LPS and TNF-α, IL-1β, IL-6 levels in group P were significantly higher than those in group C; all the above indicators in group PR were significantly higher than those in group P and group R, and LPS and IL-6 levels showed a synergistic increase (P < 0.05). Oral microbiota analysis found that microwave radiation further reduced microbial diversity on the basis of periodontitis, leading to increased relative abundances of Lactobacillus and Enterococcus, and decreased relative abundances of Staphylococcus. Correlation analysis confirmed that these differential bacterial genera were positively correlated with brain inflammation levels and negatively correlated with cognitive function indicators. Conclusion Microwave radiation exposure can exacerbate cognitive impairment in mice with experimental periodontitis, and its mechanism may be related to aggravated local periodontal damage, disruption of oral microbiota homeostasis, and subsequent induction of systemic and central neuroinflammatory cascades.

Objective To explore the value of Vision Transformer(ViT)fusion network assisted multiparametric MRI for diagnosing intracranial large vessel stenosis/occlusion(LVSO).Methods Totally 221 cases of ischemic stroke(IS)were retrospectively enrolled as test set,while other 28 cases of IS were taken as validation set,and data of diffusion weighted imaging(DWI),3D pseudo-continuous arterial spin labeling(3D-pCASL)and CT angiography(CTA)were collected.Taken CTA as reference standard,the value of ViT fusion network based on DWI,3D-pCASL and their combination for diagnosing intracranial LVSO were observed.Results In test set,the area under the curve(AUC)of ViT fusion network based on DWI,3D-pCASL and their combination for diagnosing intracranial LVSO was 0.879,0.908 and 0.925,respectively,no significant difference was found between each two(all P＞0.05),but AUC of DWI+3D-pCASL was slightly higher than that of the other two.In validation set,the AUC of ViT fusion network based on DWI+3D-pCASL for diagnosing intracranial LVSO was 0.850.Conclusion The performance of ViT fusion network based on DWI combined with 3D-pCASL for diagnosing intracranial LVSO was better.

Objective To explore the value of Vision Transformer(ViT)fusion network assisted multiparametric MRI for diagnosing intracranial large vessel stenosis/occlusion(LVSO).Methods Totally 221 cases of ischemic stroke(IS)were retrospectively enrolled as test set,while other 28 cases of IS were taken as validation set,and data of diffusion weighted imaging(DWI),3D pseudo-continuous arterial spin labeling(3D-pCASL)and CT angiography(CTA)were collected.Taken CTA as reference standard,the value of ViT fusion network based on DWI,3D-pCASL and their combination for diagnosing intracranial LVSO were observed.Results In test set,the area under the curve(AUC)of ViT fusion network based on DWI,3D-pCASL and their combination for diagnosing intracranial LVSO was 0.879,0.908 and 0.925,respectively,no significant difference was found between each two(all P＞0.05),but AUC of DWI+3D-pCASL was slightly higher than that of the other two.In validation set,the AUC of ViT fusion network based on DWI+3D-pCASL for diagnosing intracranial LVSO was 0.850.Conclusion The performance of ViT fusion network based on DWI combined with 3D-pCASL for diagnosing intracranial LVSO was better.

Objective:To provide references for disease diagnosis, treatment and aeromedical assessment by analyzing the characteristics of neurosurgical diseases in hospitalized military flying personnel.Methods:The case data and aeromedical assessment conclusions of 56 military flying personnel admitted to the Neurosurgery Department of Air Force Medical Center from 2010 to 2020 were collected. The diagnosis and treatment, as well as the flight post and aircraft type were retrospectively analyzed against the assessment conclusions.Results:The constituent ratio descending order of the neurosurgical diseases in the flying personnel was cerebrovascular disease (35.71%), central nervous system tumors (17.86%), sellar lesions (17.86%), arachnoid cysts (16.07%), traumatic brain injury (5.36%), scalp tumors (3.57%) and syringomyelia (3.57%) respectively. Among the 20 patients with cerebrovascular diseases, 5 received surgical treatment and other 15 received conservative treatment. In which 10 cases were qualified or restricted qualified, 9 cases were temporarily grounded, and 1 case was disqualified for flight. Among the 10 cases with central nervous system tumor, 5 received surgical treatment, 1 received radiotherapy and 4 received conservative treatment. In which 3 cases were qualified or restricted qualified, 3 cases were temporarily grounded and 4 cases were disqualified for flight. Among the 10 cases with saddle area lesions, 2 received surgical treatment, 3 received medical treatment and other 5 were observed by followed up. In which 8 cases were qualified or restricted qualified, 1 was temporarily grounded and 1 was disqualified for flight. Among the 9 cases with arachnoid cysts, 1 received surgical treatment and 8 received conservative treatment. In which 5 cases were qualified or restricted qualified, 1 was temporarily grounded and 3 were disqualified for flight. Among the other 7 cases, 5 received medical treatment or observed by follow-up, and 2 received surgical treatment. In which 6 cases were qualified for flight and 1 was temporarily grounded.Conclusions:Neurosurgical diseases should be paid more for flight safety due to quite a few restricted qualified, temperedly grounding or disqualified cases existed in the military flying personnel with such diseases.

Objective:To provide references for disease diagnosis, treatment and aeromedical assessment by analyzing the characteristics of neurosurgical diseases in hospitalized military flying personnel.Methods:The case data and aeromedical assessment conclusions of 56 military flying personnel admitted to the Neurosurgery Department of Air Force Medical Center from 2010 to 2020 were collected. The diagnosis and treatment, as well as the flight post and aircraft type were retrospectively analyzed against the assessment conclusions.Results:The constituent ratio descending order of the neurosurgical diseases in the flying personnel was cerebrovascular disease (35.71%), central nervous system tumors (17.86%), sellar lesions (17.86%), arachnoid cysts (16.07%), traumatic brain injury (5.36%), scalp tumors (3.57%) and syringomyelia (3.57%) respectively. Among the 20 patients with cerebrovascular diseases, 5 received surgical treatment and other 15 received conservative treatment. In which 10 cases were qualified or restricted qualified, 9 cases were temporarily grounded, and 1 case was disqualified for flight. Among the 10 cases with central nervous system tumor, 5 received surgical treatment, 1 received radiotherapy and 4 received conservative treatment. In which 3 cases were qualified or restricted qualified, 3 cases were temporarily grounded and 4 cases were disqualified for flight. Among the 10 cases with saddle area lesions, 2 received surgical treatment, 3 received medical treatment and other 5 were observed by followed up. In which 8 cases were qualified or restricted qualified, 1 was temporarily grounded and 1 was disqualified for flight. Among the 9 cases with arachnoid cysts, 1 received surgical treatment and 8 received conservative treatment. In which 5 cases were qualified or restricted qualified, 1 was temporarily grounded and 3 were disqualified for flight. Among the other 7 cases, 5 received medical treatment or observed by follow-up, and 2 received surgical treatment. In which 6 cases were qualified for flight and 1 was temporarily grounded.Conclusions:Neurosurgical diseases should be paid more for flight safety due to quite a few restricted qualified, temperedly grounding or disqualified cases existed in the military flying personnel with such diseases.

Crohn's disease (CD) is a chronic nonspecific inflammatory disease.CD can affect any location in the digestive tract,and it also affect other organs,including the eyes,skin,liver and joints,which are termed extraintestinal manifestations (EIMs).The cutaneous manifestations of CD are common and occur in about one-third of patients.EIMs of CD have been divided into 3 categories.(1) Specific lesion,cutaneous manifestations of CD were the same as histopathologic findings of underlying gastrointestinal lesion.(2) Reactive lesion,it was also inflammatory lesion which was usually accompanied by underlying gastrointestinal disease while inflammatory injury was different from histopathologic findings of gastrointestinal lesion.(3) Associated lesion,it was caused by sequelae of human leucocyte antigen and chronic inflammation.In the current era of ever-expanding therapeutic options for CD,some investigators have proposed a fourth category of EIMs,namely those that are therapy-related lesion.The therapy-related lesion is closely related to disease-associated conditions in light of certain skin findings,and there is potential overlap between them.

Objective To evaluate the efficacy and safety of focal fractional laser treatment(FFLT)for atrophic acne scars. Methods A randomized, self-controlled study was performed. A total of 20 patients with atrophic facial acne scars were enrolled into this study. Treatments were randomly administered in a split-face manner. Half of each subject′s face received FFLT(FFLT side), and the other half underwent full-face fractional CO2 laser resurfacing(control side), for one session. All the patients were followed up for 3 months after the treatment. Evaluation was based on the ECCA grading scale (échelle d′évaluation clinique des cicatrices d′acné)and patient satisfaction score. A VISIA skin detector was used to take photographs and evaluate skin texture. Moreover, physical parameters of the skin, including erythema index, melanin index and transepidermal water loss (TEWL), were measured. Adverse effects were recorded and evaluated. Statistical analysis was carried out by paired t test, Wilcoxon paired rank test, Fisher′s exact test and repeated-measure analysis of variance. Results The ECCA score decreased from 51.24 ± 17.61 at the baseline to 34.46 ± 14.99 at 3 months after the treatment at the FFLT side(t = 7.886, P < 0.05), and from 50.96 ± 18.96 to 38.29 ± 14.86 at the control side(t =6.123, P < 0.05), and was significantly lower in the FFLT side than in the control side (t = 4.462, P < 0.05)at 3 months after the treatment. The improvement rate was significantly higher in the FFLT side than in the control side (32.75% vs. 24.86%, P = 0.016 by Fisher′s exact test)at 3 months after the treatment. Decreased pain and edema scores were observed at the FFLT side compared with the control side at 1 hour after the treatment (both P < 0.05), but no significant difference was noted in the duration of erythema or crusting between the two sides (both P > 0.05). Compared with those before the treatment, skin texture scores decreased in both sides (both P < 0.05), and were significantly lower in the FFLT side than in the control side at 3 months after the treatment(P < 0.05). The erythema index was significantly lower in the FFLT side than in the control side in both scarred areas and non-scarred areas on day 1 after the treatment (both P < 0.05). Both melanin index and TEWL at the FFLT side were significantly increased in scarred areas, but decreased in non-scarred areas compared with those at the control side within 3 days after the treatment (all P < 0.05). Similarly, the water content of the stratum corneum at the FFLT side was significantly lower in scarred areas, but higher in non-scarred areas compared with that at the control side between day 1 and 7 after the treatment (both P < 0.05). No significant difference was observed in the erythema index, TEWL or water content of the stratum corneum between the FFLT side and control side at scarred areas or non-scarred areas(all P > 0.05)from 2 weeks to 3 months after the treatment(all P > 0.05). Conclusion FFLT can improve therapeutic outcomes in atrophic acne scars with reduced adverse reactions.

OBJECTIVETo evaluate the efficacy of ligation of intersphincteric fistula tract (LIFT) in the treatment of complex fistula-in-ano.

METHODSClinical data of 24 patients with complex fistula-in-ano who treated with LIFT in the Affiliated Hospital of Nanjing University of Chinese Medicine from September 2009 to February 2012 were analyzed retrospectively. The operative efficacy and postoperative continence were evaluated.

RESULTSThe prime success rate of fistula healing was 66.7% (16/24) after the LIFT procedure. Two patients presented with intersphincteric incision infection which was successfully treated with topical of silver nitrate. Four patients had intersphincteric fistula with infection and managed with the complete laying open approach. The total clinical healing rate was 91.7% (22/24). Another 2 patients had persistent external opening with discharge. During follow-up of 6 to 44 (median 16) months, The Cleveland Clinic Florida Fecal Incontinence score revealed that no patient developed decreased continence.

CONCLUSIONLIFT is a safe and effective sphincter-preserve procedure for complex fistula-in-ano.

Objective To evaluate the efficacy of ligation of intersphincteric fistula tract (LIFT) in the treatment of complex fistula-in-ano. Methods Clinical data of 24 patients with complex fistula-in-ano who treated with LIFT in the Affiliated Hospital of Nanjing University of Chinese Medicine from September 2009 to February 2012 were analyzed retrospectively. The operative efficacy and postoperative continence were evaluated. Results The prime success rate of fistula healing was 66.7%(16/24) after the LIFT procedure. Two patients presented with intersphincteric incision infection which was successfully treated with topical of silver nitrate. Four patients had intersphincteric fistula with infection and managed with the complete laying open approach. The total clinical healing rate was 91.7%(22/24). Another 2 patients had persistent external opening with discharge. During follow-up of 6 to 44 (median 16) months, The Cleveland Clinic Florida Fecal Incontinence score revealed that no patient developed decreased continence. Conclusion LIFT is a safe and effective sphincter-preserve procedure for complex fistula-in-ano.

Objective To evaluate the efficacy of ligation of intersphincteric fistula tract (LIFT) in the treatment of complex fistula-in-ano. Methods Clinical data of 24 patients with complex fistula-in-ano who treated with LIFT in the Affiliated Hospital of Nanjing University of Chinese Medicine from September 2009 to February 2012 were analyzed retrospectively. The operative efficacy and postoperative continence were evaluated. Results The prime success rate of fistula healing was 66.7%(16/24) after the LIFT procedure. Two patients presented with intersphincteric incision infection which was successfully treated with topical of silver nitrate. Four patients had intersphincteric fistula with infection and managed with the complete laying open approach. The total clinical healing rate was 91.7%(22/24). Another 2 patients had persistent external opening with discharge. During follow-up of 6 to 44 (median 16) months, The Cleveland Clinic Florida Fecal Incontinence score revealed that no patient developed decreased continence. Conclusion LIFT is a safe and effective sphincter-preserve procedure for complex fistula-in-ano.